Second dose range finding trial of grass pollen allergy immunotherapy in US

Trial Profile

Second dose range finding trial of grass pollen allergy immunotherapy in US

Planning
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2016

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Jun 2016 New trial record
    • 27 Jun 2016 According to an Allergy Therapeutics media release, this trial is expected to initiate in 2017.
    • 27 Jun 2016 According to an Allergy Therapeutics media release, this trial will employ same trial design as successful European dose-finding trial for birch pollen product (Pollinex Quattro Birch) (see profile 700262266).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top